CORC  > 中南大学
A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia
Zhao, Xu; Wu, Ju-Fang; Xiu, Qing-Yu; Wang, Chen; Zhang, De-Ping; Huang, Jian-An; Xie, Can-Mao; Sun, Sheng-Hua; Lv, Xiao-Ju; Si, Bin
刊名Diagnostic Microbiology and Infectious Disease
2014
卷号80期号:2页码:141-147
关键词Community-acquired pneumonia Levofloxacin Clinical trial Efficacy Safety
ISSN号0732-8893
DOI10.1016/j.diagmicrobio.2013.11.008
URL标识查看原文
WOS记录号WOS:000342329200010
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3344632
专题中南大学
作者单位1.[Wu, Ju-Fang
2.Zhao, Xu
3.Zhang, Ying-Yuan] Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai 200040, Peoples R China.
推荐引用方式
GB/T 7714
Zhao, Xu,Wu, Ju-Fang,Xiu, Qing-Yu,et al. A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia[J]. Diagnostic Microbiology and Infectious Disease,2014,80(2):141-147.
APA Zhao, Xu.,Wu, Ju-Fang.,Xiu, Qing-Yu.,Wang, Chen.,Zhang, De-Ping.,...&Zhang, Ying-Yuan.(2014).A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia.Diagnostic Microbiology and Infectious Disease,80(2),141-147.
MLA Zhao, Xu,et al."A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia".Diagnostic Microbiology and Infectious Disease 80.2(2014):141-147.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace